Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Certara

Certara Announces 300th Regulatory Submission Milestone Using its Technology-enabled Services and Software
From Certara
Via GlobeNewswire
Tickers CERT
Certara to Participate in Upcoming Investor Conferences
From Certara
Via GlobeNewswire
Tickers CERT
Certara Simcyp™ Group Awarded Two New Grants from US FDA
From Certara
Via GlobeNewswire
Tickers CERT
Certara Reports Second Quarter 2023 Financial Results
From Certara
Via GlobeNewswire
Tickers CERT
Certara to Report Second Quarter 2023 Financial Results on August 9th, 2023
From Certara
Via GlobeNewswire
Tickers CERT
Certara to Participate in the Jefferies Global Healthcare Conference
From Certara
Via GlobeNewswire
Tickers CERT
Certara Reports First Quarter 2023 Financial Results
From Certara
Via GlobeNewswire
Tickers CERT
Certara Customers Received 90 Percent of US FDA Novel Drug Approvals for 9th Consecutive Year
From Certara
Via GlobeNewswire
Tickers CERT
Certara to Report First Quarter 2023 Financial Results on May 8th, 2023 and Participate in the BofA Securities 2023 Healthcare Conference
From Certara
Via GlobeNewswire
Tickers CERT
A.I. Coming to Certara’s D360 Scientific Informatics Software
From Certara
Via GlobeNewswire
Tickers CERT
Certara announces the release of Simcyp™ PBPK Simulator Version 22, expanding ability to simulate untested scenarios for new patient and therapeutic types
From Certara
Via GlobeNewswire
Tickers CERT
Certara Reports Fourth Quarter and Full Year 2022 Financial Results
From Certara
Via GlobeNewswire
Tickers CERT
Certara Announces Transition Plan for Chief Financial Officer
From Certara
Via GlobeNewswire
Tickers CERT
Certara to Participate in the Barclays Global Healthcare Conference
From Certara
Via GlobeNewswire
Tickers CERT
Certara to Report Fourth Quarter and Full Year 2022 Financial Results on March 1st, 2023
From Certara
Via GlobeNewswire
Tickers CERT
Certara Acquires Vyasa, an Artificial Intelligence Company that Delivers Predictions to Accelerate Scientific Innovation
From Certara
Via GlobeNewswire
Tickers CERT
Certara Announces the Completion of Arsenal Capital Partners’ Investment and the Appointment of David Spaight to the Board of Directors
From Certara
Via GlobeNewswire
Tickers CERT
Certara Reports Third Quarter 2022 Financial Results
From Certara
Via GlobeNewswire
Tickers CERT
Arsenal Capital Partners Increases Investment in Global Biosimulation Leader Certara with $449M Stock Purchase
From Certara
Via GlobeNewswire
Tickers CERT
Certara to Participate in Upcoming Investor Conferences
From Certara
Via GlobeNewswire
Tickers CERT
Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) Renews Licenses of Certara’s Software for Evaluating Regulatory Submissions
From Certara
Via GlobeNewswire
Tickers CERT
Certara to Report Third Quarter 2022 Financial Results on November 7th, 2022
From Certara
Via GlobeNewswire
Tickers CERT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.